文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Identifying health conditions associated with an increased risk of pancreatic ductal adenocarcinoma at medium term in nationwide electronic health records of primary care physicians.

作者信息

Rassy Elie, Delaloge Suzette, Slaouti Yannis, Pudlarz Thomas, Lekens Béranger, Boilève Alice, Michiels Stefan, Karimi Mariam

机构信息

Department of Cancer Medicine, Gustave Roussy, University Paris-Saclay, Villejuif, France.

Department of Biostatistics and Epidemiology, Gustave Roussy, University Paris-Saclay, Villejuif, France.

出版信息

Br J Cancer. 2025 Aug 30. doi: 10.1038/s41416-025-03172-5.


DOI:10.1038/s41416-025-03172-5
PMID:40885830
Abstract

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) presents an urgent challenge that necessitates improved early risk identification. We investigated the association between predictors of PDAC present at least two years before diagnosis and PDAC occurence. METHODS: This case-control study used electronic health records from The Health Improvement Network Database (UK). Cases (10,575) were matched with controls (105,750) in a 1:10 ratio by gender, age, follow-up duration, and year of inclusion in the database. Variables included clinical features, comorbidities and blood result abnormalities, reported at least 2 years before PDAC diagnosis or equivalent timeframe for controls. Conditional logistic regression model with backward estimated odds ratios (OR) and 95% confidence interval (CI). RESULTS: Electronic health records of cases reported higher prevalence of alcohol intake, cigarette smoking, dyslipidemia, increased blood pressure, and diabetes of more than four years' duration. Independent risk factors included pancreatic cysts (OR = 4.39), pancreatitis (OR = 2.16), dyslipidemia (OR = 1.50), smoking (OR = 1.09), and alcohol intake (OR = 1.09). Laboratory markers associated with higher risk included elevated alkaline phosphatase (OR = 3.21), bilirubin (OR = 2.48), alanine aminotransferase (OR = 1.76), erythrocyte sedimentation rate (OR = 1.27), and decreased albumin (OR = 1.54). CONCLUSIONS: Primary care electronic records can identify individuals at medium-term increased risk of PDAC, thus raises the opportunity to develop early detection models and address modifiable factors.

摘要

相似文献

[1]
Identifying health conditions associated with an increased risk of pancreatic ductal adenocarcinoma at medium term in nationwide electronic health records of primary care physicians.

Br J Cancer. 2025-8-30

[2]
Prescription of Controlled Substances: Benefits and Risks

2025-1

[3]
Electronic cigarettes for smoking cessation and reduction.

Cochrane Database Syst Rev. 2014

[4]
Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis.

Health Technol Assess. 2021-10

[5]
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.

Clin Orthop Relat Res. 2024-12-1

[6]
Electronic cigarettes for smoking cessation.

Cochrane Database Syst Rev. 2021-9-14

[7]
Electronic cigarettes for smoking cessation.

Cochrane Database Syst Rev. 2022-11-17

[8]
A systematic review of evidence on malignant spinal metastases: natural history and technologies for identifying patients at high risk of vertebral fracture and spinal cord compression.

Health Technol Assess. 2013-9

[9]
Incentives for smoking cessation.

Cochrane Database Syst Rev. 2025-1-13

[10]
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

Health Technol Assess. 2008-6

本文引用的文献

[1]
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

CA Cancer J Clin. 2024

[2]
GLP-1 Receptor Agonists and Colorectal Cancer Risk in Drug-Naive Patients With Type 2 Diabetes, With and Without Overweight/Obesity.

JAMA Oncol. 2024-2-1

[3]
Use and persistence of single and multiple inhaler triple therapy prescribed for patients with COPD in France: a retrospective study on THIN database (OPTI study).

BMJ Open Respir Res. 2023-6

[4]
Association of Adherence to Endocrine Therapy Among Patients With Breast Cancer and Potential Drug-Drug Interactions.

JAMA Netw Open. 2022-12-1

[5]
Increased risk of pancreatic cancer in individuals with non-alcoholic fatty liver disease.

Sci Rep. 2022-6-23

[6]
Identifying health conditions associated with Alzheimer's disease up to 15 years before diagnosis: an agnostic study of French and British health records.

Lancet Digit Health. 2022-3

[7]
Predicting Pancreatic Cancer in the UK Biobank Cohort Using Polygenic Risk Scores and Diabetes Mellitus.

Gastroenterology. 2022-5

[8]
A narrative review on the validity of electronic health record-based research in epidemiology.

BMC Med Res Methodol. 2021-10-27

[9]
Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors.

Nat Rev Gastroenterol Hepatol. 2021-7

[10]
A clinical prediction model to assess risk for pancreatic cancer among patients with prediabetes.

Eur J Gastroenterol Hepatol. 2022-1-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索